Materiovigilance Programme of India (MvPI) to monitor the safety of medical devices in the country has been approved for the commencement by the Ministry of Health & Family Welfare, Govt. of India. The MvPI is formally launched on 06^th July 2015 at IPC, Ghaziabad by DCG(I). The Indian Pharmacopoeia Commission functions as National Coordination Centre for MvPI. Sree Chitra Tirunal Institute of Medical Sciences & Technology (SCTIMST) will be function as National Collaborating Centre. National Health Systems Resource Centre (NHSRC) under MoHFW, Govt. of India working as technical support and resource centre. After inaugurating the event DCG(I) mentioned that MvPI is necessary steps to ensure the patient safety because medical device monitoring also equally important like drugs. He asked all the stakeholders to support for national cause. After the inauguration the technical committee meeting such as steering committee and working group meeting were held and important decision such as identification of 10 Adverse effect Monitoring Centers and data management system etc. were discussed.

                                                        Dr.G.N.Singh DCG(I) along with other experts during the launch of MvPI.